Dalfampridine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62756-429 -
Package NDC
62756-429-86 -
Application number
ANDA208292 -
SPL ID
c3c3b8ae-9dac-40fc-8569-b26d6befbf01 -
SPL set ID
d61e15fa-0334-49a0-ab41-c9a36b726b57 -
UNII
BH3B64OKL9 -
RxCUI
897021
What the source publishes
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Active ingredients
- Dalfampridine
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Dalfampridine",
"splId": "c3c3b8ae-9dac-40fc-8569-b26d6befbf01",
"labels": [
{
"setId": "d61e15fa-0334-49a0-ab41-c9a36b726b57",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d61e15fa-0334-49a0-ab41-c9a36b726b57",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d61e15fa-0334-49a0-ab41-c9a36b726b57"
}
],
"routes": [
"ORAL"
],
"labeler": "Sun Pharmaceutical Industries, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (62756-429-86)",
"package_ndc": "62756-429-86",
"identifierStatus": "well-formed",
"marketing_start_date": "20190522"
}
],
"productId": "62756-429_c3c3b8ae-9dac-40fc-8569-b26d6befbf01",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "62756-429",
"deaSchedule": null,
"genericName": "Dalfampridine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DALFAMPRIDINE",
"strength": "10 mg/1"
}
],
"applicationNumber": "ANDA208292",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190522",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000192795",
"N0000175448"
],
"unii": [
"BH3B64OKL9"
],
"rxcui": [
"897021"
],
"spl_set_id": [
"d61e15fa-0334-49a0-ab41-c9a36b726b57"
],
"pharm_class_epc": [
"Potassium Channel Blocker [EPC]"
],
"pharm_class_moa": [
"Potassium Channel Antagonists [MoA]"
],
"manufacturer_name": [
"Sun Pharmaceutical Industries, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62756-429_c3c3b8ae-9dac-40fc-8569-b26d6befbf01"